Nodular Lymphocyte Predominant B-Cell Lymphoma
2 clinical trials · Condition
◉ Watch Nodular Lymphocyte Predominant B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial (NCT05886036) | National Cancer Institute (NCI) | 2024-01-23 |
| Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275) | National Cancer Institute (NCI) | 2021-05-20 |
Track Nodular Lymphocyte Predominant B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.